Is OVX1 a Suitable Marker for Endometrial Cancer?

By Beck E.P.   Wagner M.   Anselmino L.   Xu F.-j.   Bast R.C.   Jaeger W.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 291-296

Elsevier

Access to resources Recommend Favorite

Persistent Chemosensitivity to Platinum and/or Paclitaxel in Metastatic Endometrial Cancer

By Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 422-423

Elsevier

Access to resources Recommend Favorite

Estrogen Receptor Immunocytochemistry in Endometrial Carcinoma: A Prognostic Marker for Survival

By Pertschuk L.P.   Masood S.   Simone J.   Feldman J.G.   Fruchter R.G.   Axiotis C.A.   Greene G.L.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 28-33

Academic Press

Access to resources Recommend Favorite

CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancer

By Zhang Haofeng   Zhang Jun   Wang Zhaoqing   Lu Di   Feng Jing   Yang Dongling   Chen Xiuqin   Yan Xiyun  

Oncology Letters, Vol. 5, Iss. 4, 2013-04 ,pp. : 1189-1194

Spandidos Publications

Access to resources Recommend Favorite

Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia

By Lowe M.P.   Cooper B.C.   Sood A.K.   Davis W.A.   Syrop C.H.   Sorosky J.I.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 569-572

Elsevier

Access to resources Recommend Favorite